CLDN2 and colorectal cancer: To gain insights into the mechanism whether CLDN2 regulated downstream EMT genes, we next analysed the expression profiles of EMT‐signature markers in colorectal cancer cells with either stable CRISPR‐mediated CLDN2 knockout or CLDN2 overexpression.